Press
He
Weizmann Wonder Wander
Science news and culture
Search
echo t('Click') ?>
X
Menu
Home Page
Area of Research
Math & Computer Science
People
Space & Physics
Chemistry
Life Sciences
Environment
Science Teaching
Scientific Archaeology
Technology & Applications
The Campus
The Website
For Journalists
RSS Service
Subscribe to our monthly newsletter/press releases
He
Skip to Home
Skip to Search
Skip to Content
Skip to Contact us
Skip to Sitemap
Skip to Accessibility Statement
Press Releases
All Press Releases
Receive Press Releases
RSS
News
Top Stories
Subscribe to our Monthly Newsletter
Explore Topics
Math and Computer Science
Space and Physics
Chemistry
Life Sciences
Environment
More
Scientific Archaeology
Science Teaching
Technology & Applications
People and Events
Awards and Appointments
People
Events
Science on Tap
Conferences
On Campus
Art on Campus
All People and Events
Multimedia
The Beauty of Science
Videos and Lectures
Nano Comics
Around Campus
More
Publications
Special Issues
Blue Sky Research
Planting Knowledge
100 Milestones in Physics
Art on Campus
All Special Issues
Buildings on Campus
What the Tree Has
Weizmann International Magazine of Science and People
About
About the Weizmann Institute of Science
Facts and Figures
Dr. Chaim Weizmann
Visit the Weizmann Institute of Science
Follow Us
Are you a journalist?
Please sign up here for our press releases
Subscribe to our monthly newsletter:
First name
Last name
Email
*
Agreement
*
I agree to the
Terms of Use
and
Cookie & Privacy Policy
You are here
Home
>
News
> All Press Releases
Press Releases
Search
Choose Topic
Math & Computer Science
Space & Physics
Chemistry
Life Sciences
Environment
Technology & Applications
Choose Language
English
French
German
Portuguese
Spanish
1997 Teva Founders Prize To Weizmann Institute's Prof. David Wallach
22.03.1998
REHOVOT, Israel - March 22, 1998 - Prof. David Wallach of the Weizmann Institute of Science's Biological Chemistry Department has been awarded the 1997 Teva Founders Prize.
Sales of Products Emanating from Weizmann Institute Research - $600 million in 1997
19.03.1998
Technology & Applications
REHOVOT, Israel - March 19, 1998 - Approximately $600 million worth of products emanating from research at the Weizmann Institute of Science were sold by Israeli and non-Israeli companies in 1997. Israeli companies were responsible for half of these sales, mainly for export. These figures derive from a survey conducted by the Tel Aviv-based accounting firm Kost Levary & Forer, a member of Ernst & Young International.
'Green' Approach May Significantly Improve Cancer Therapy
03.02.1998
REHOVOT, Israel - February 3, 1998 - A promising cancer therapy which destroys tumors by exposing them to light may be significantly improved thanks to new materials developed at the Weizmann Institute of Science. Institute scientists reported on the new development at the Conference on Chemical Modifiers of Cancer Treatment in Clearwater, Florida, on January 28-31.
Weizmann Institute Astrophysicist Hot on the Tracks of a New "Strange" Star
12.01.1998
REHOVOT, Israel - January 12, 1998 - A new "strange" star is suspected to be lurking in our galaxy - and a Weizmann Institute astrophysicist is hot on its tracks.
Cellular Short Circuit Causes Insulin Resistance
01.01.1998
Biochemistry
Future treatments for diabetes may correct the underlying causes of this prevalent metabolic disorder rather than just treat its symptoms. An important step in this direction has been made by Prof. Yehiel Zick of the Weizmann Institute's Molecular Cell Biology Department.
The Envelope Please....
01.01.1998
Math & Computer Science
Two managers have run into a delicate problem. Each has received a complaint from a company employee on a sensitive matter. In both cases, the complainer has requested to keep his identity confidential. The managers would like to determine whether the same person has complained to both of them, but how can they do this without revealing to each other their complainers' identity?
Neatness Pays
01.01.1998
Chemistry
Catalysts are the pacesetters of the chemical industry, speeding reactions that are vital to the manufacture of a host of products such as drugs, synthetic fibers and plastics. Now researchers at the Weizmann Institute of Science have found that a catalyst's performance can be dramatically improved by adjusting the structural orientation of its molecules.
Imaging Method Reveals Remarkable 'Architecture' of the Working Brain
16.12.1997
Brain & Behavior
REHOVOT, Israel - December 16, 1997 - With thousands of neurons firing signals in all directions and forming trillions of possible connections, you'd expect the working brain to be a messy place. Yet a new study conducted by researchers from Max Planck Institute of Psychiatry in Martinsried, Germany, and Israel's Weizmann Institute of Science reveals that brain cells engaged in different tasks in the visual cortex form "mosaics" which are amazingly orderly and elegant.
In Gulliver's Garden: Tiny Tomatoes Speed Genetic Engineering of Plants
10.12.1997
Plants and Agriculture
REHOVOT, Israel - December 10, 1997 - A tiny tomato, dubbed "Micro-Tom," may mean big news for genetic engineering. The Lilliputian plant, adapted for research by Dr. Avraham Levy of the Weizmann Institute of Science, is the key to a new method that may speed the process of unraveling the genetic code of plants, making it easier to identify and use commercially valuable genes.
Windows on your Mind: Weizmann Institute Scientists Reveal That Imagination Can Enhance Visual Perception
09.12.1997
Brain & Behavior
REHOVOT, Israel - December 9, 1997 - Conjuring up images in the "mind's eye" enhances our ability to see what's really there, Weizmann Institute scientists have found. However, imagination greases the wheels of perception only when the images are drawn from short-term memory, the researchers report in the current issue of the Journal of Cognitive Neuroscience.
Pages
« first
‹ previous
…
65
66
67
68
69
70
71
72
73
…
next ›
last »
Are you a journalist?
Please sign up here for our press releases
Most Popular Articles
The Coin Toss Paradox
Can a game with “quantum” rules beat the odds?
Prof. Zvi Artstein, Vice President for Technology Transfer
Prof. Zvi Artstein
One Protein, Two Programs
A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms
Accessibility Toolbar
❌
+
Enlarge text
-
Reduce text
Monochrome
Contrast
Underline Links
Reset
Accessibility Statement